Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Inflammation-Related Biomarkers Linking Environmental Chemical Mixtures and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Population-Based Study from NHANES 1999–2020. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1097/hep.0000000000000520
10.1097/hep.0000000000000520 · External reference
10.1053/j.gastro.2019.11.312
10.1053/j.gastro.2019.11.312 · External reference
10.1016/j.jhep.2020.03.039
10.1016/j.jhep.2020.03.039 · External reference
10.1016/j.metabol.2023.155664
10.1016/j.metabol.2023.155664 · External reference
10.1016/j.metabol.2020.154318
10.1016/j.metabol.2020.154318 · External reference
Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review[J]
10.7570/jomes23052 · 2023 · External reference
Liver diseases in the Asia-pacific region: a lancet gastroenterology & hepatology commission[J]
10.1016/s2468-1253(19)30342-5 · 2020 · External reference
Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association[J]. Arteriosclerosis
2022 · External reference
Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block[J]
10.2174/1570161117666190405164313 · 2020 · External reference
10.1136/bmj-2023-076388
10.1136/bmj-2023-076388 · External reference
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention[J]
10.1038/nrgastro.2017.109 · 2018 · External reference
Epidemiology of obesity in adults: latest trends[J]
10.1007/s13679-018-0317-8 · 2018 · External reference
10.1016/j.metabol.2018.11.014
10.1016/j.metabol.2018.11.014 · External reference
Endocrine-disrupting chemicals and fatty liver disease[J]
10.1038/nrendo.2017.42 · 2017 · External reference
The interplay between endocrine-disrupting chemicals and the epigenome towards metabolic dysfunction-associated steatotic liver disease: a comprehensive review[J]
10.3390/nu16081124 · 2024 · External reference
Endocrine disruptors and developmental origins of nonalcoholic fatty liver disease[J]
10.1210/en.2017-00887 · 2018 · External reference
Phthalates and diet: a review of the food monitoring and epidemiology data[J]
10.1186/1476-069x-13-43 · 2014 · External reference
10.1016/j.envres.2021.111190
10.1016/j.envres.2021.111190 · External reference
10.1016/j.ecoenv.2025.117762
10.1016/j.ecoenv.2025.117762 · External reference
Serum glycolipids mediate the relationship of urinary bisphenols with NAFLD: analysis of a population-based, cross-sectional study[J]
10.1186/s12940-022-00945-w · 2023 · External reference
Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017-2018[J]
10.1007/s10552-024-01865-5 · 2024 · External reference
10.1016/j.chemosphere.2023.139753
10.1016/j.chemosphere.2023.139753 · External reference
Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: a population-based study in korea[J]
10.1016/j.ecoenv.2024.116310 · 2024 · External reference
10.1016/j.envpol.2022.119915
10.1016/j.envpol.2022.119915 · External reference
Exposure to volatile organic compounds and polycyclic aromatic hydrocarbons is associated with the risk of non-alcoholic fatty liver disease in korean adolescents: korea national environmental health survey (KoNEHS) 2015–2017[J]
10.1016/j.ecoenv.2023.114508 · 2023 · External reference
10.1016/j.envint.2023.108138
10.1016/j.envint.2023.108138 · External reference
Exposome Profiling of Environmental Pollutants in Seminal Plasma and Novel Associations with Semen Parameters[J]
10.1021/acs.est.3c10314 · 2024 · External reference
Principal Component Pursuit for Pattern Identification in Environmental Mixtures[J]
10.1289/ehp10479 · 2022 · External reference
Robust principal component analysis?[J]
2011 · External reference
Exploring the nexus between hypothyroidism and metabolic dysfunction-associated steatotic liver disease: A UK biobank cohort study[J]
10.1038/s41598-025-91221-7 · 2025 · External reference
Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management[J]
10.1210/endrev/bnz009 · 2020 · External reference
Low-grade systemic inflammation links heavy metal exposures to mortality: A multi-metal inflammatory index approach[J]
10.1016/j.scitotenv.2024.174537 · 2024 · External reference
The pathophysiology of MASLD: An immunometabolic perspective[J]
10.1080/1744666x.2023.2294046 · 2024 · External reference
Potential role of inflammation in relation to dietary sodium and β-carotene with non-alcoholic fatty liver disease: A mediation analysis[J]
2022 · External reference
Association between Volatile Organic Compound Exposure and Sex Hormones in Adolescents: The Mediating Role of Serum Albumin[J]
10.3390/toxics12060438 · 2024 · External reference
Elevated hemoglobin level is associated with advanced fibrosis in pediatric nonalcoholic fatty liver disease[J]
10.1097/mpg.0000000000001614 · 2017 · External reference
Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease[J]
10.3748/wjg.v28.i38.5636 · 2022 · External reference
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis[J]
10.1016/j.jhep.2017.12.027 · 2018 · External reference
Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018[J]
10.1038/s41598-025-88685-y · 2025 · External reference
Unresolved reference
External reference
10.1080/1047322x.1990.10389587
10.1080/1047322x.1990.10389587 · External reference
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease[J]
10.3350/cmh.2022.0096 · 2022 · External reference
10.1111/apt.13012
10.1111/apt.13012 · External reference
The neutrophil-to-lymphocyte ratio predicts all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease: evidence from the national health and nutrition examination survey 1999 to 2018[J]
10.1097/md.0000000000048962 · 2026 · External reference
Relationship between phthalates exposures and metabolic dysfunction-associated fatty liver disease in United States adults[J]
10.1371/journal.pone.0301097 · 2024 · External reference
10.1016/j.ecoenv.2021.112665
10.1016/j.ecoenv.2021.112665 · External reference
Urinary phthalate levels associated with the risk of nonalcoholic fatty liver disease in adults: the korean national environmental health survey (KoNEHS) 2012-2014[J]
10.3390/ijerph18116035 · 2021 · External reference
Potential influence of the phthalates on normal liver function and cardiometabolic risk in males[J]
2017 · External reference
10.1016/j.envpol.2021.118106
10.1016/j.envpol.2021.118106 · External reference
Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters[J]
10.1093/toxsci/kfh253 · 2004 · External reference
Activation of PPARalpha and PPARgamma by environmental phthalate monoesters[J]
10.1093/toxsci/kfg145 · 2003 · External reference
Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: A cross-sectional study based on NHANES 2017 to 2018[J]
10.3389/fpubh.2024.1407976 · 2024 · External reference
10.3389/fnut.2022.1059675
10.3389/fnut.2022.1059675 · External reference
Association between phthalate exposure and metabolic dysfunction-associated steatotic liver disease (MASLD) – systematic literature review[J]
10.1016/j.envres.2025.121186 · 2025 · External reference
Associations of urinary organophosphate esters metabolites and diet quality with nonalcoholic/metabolic dysfunction-associated fatty liver diseases in adults[J]
10.1016/j.ecoenv.2023.114720 · 2023 · External reference
Environmental exposure to organophosphate esters and suspected non-alcoholic fatty liver disease among US adults: a mixture analysis[J]
10.3389/fpubh.2022.995649 · 2022 · External reference
10.3389/fimmu.2022.880298
10.3389/fimmu.2022.880298 · External reference
Inflammation, Psychiatric Symptoms, and Opioid Use Are Associated With Pain and Disability in Patients With Cirrhosis[J]
10.1016/j.cgh.2014.10.029 · 2015 · External reference
10.1126/scitranslmed.adh9940
10.1126/scitranslmed.adh9940 · External reference
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in metabolic dysfunction-associated steatotic liver disease-induced cirrhosis[J]
10.3748/wjg.v30.i7.685 · 2024 · External reference
The role of red cell distribution width as a prognostic marker in chronic liver disease: A literature review[J]
10.3390/ijms24043487 · 2023 · External reference
High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease[J]
10.1097/meg.0b013e328365c403 · 2014 · External reference
Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?[J]
10.3748/wjg.v20.i35.12711 · 2014 · External reference
Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis[J]
2015 · External reference
10.1016/j.metabol.2023.155694
10.1016/j.metabol.2023.155694 · External reference
Di(2-ethylhexyl) phthalate exacerbates non-alcoholic fatty liver in rats and its potential mechanisms[J]
10.1016/j.etap.2015.12.016 · 2016 · External reference
10.1016/j.ecoenv.2019.109611
10.1016/j.ecoenv.2019.109611 · External reference
10.3390/metabo14010012
10.3390/metabo14010012 · External reference
10.1007/s00535-013-0758-5
10.1007/s00535-013-0758-5 · External reference
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways[J]. Clinical Science (london
2022 · External reference
Altered mitochondrial function in MASLD: key features and promising therapeutic approaches[J]
10.3390/antiox13080906 · 2024 · External reference
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy[J]
10.1186/s12967-023-04367-1 · 2023 · External reference
Mitochondrial oxidative stress-a causative factor and therapeutic target in many diseases[J]
10.3390/ijms222413384 · 2021 · External reference
